Investment Banking
About Stifel Investment Banking
A premier investment bank with a broad set of capabilities
Stifel is a full-service investment bank with deep industry experience. We serve as strategic advisors to entrepreneurs, family-owned businesses, private equity groups, and leading public and private corporations in North America, Europe, Asia, Israel, and Latin America.
Our more than 750 investment banking professionals stand ready to provide the insight and expertise you require. Our integrated approach allows us to deliver the full capabilities of Stifel’s institutional capital markets platform and retail brokerage network, which are among the most highly regarded in the industry.
With over 750 Investment Banking professionals worldwide, Stifel combines deep domain knowledge, product expertise, and an entrepreneurial spirit to deliver strategic advisory services and differentiated solutions.
Learn MoreIndustry Coverage
Serving companies through specialized expertise and strong relationships within our core industries.
Product Coverage
Our full-service product offering and the expertise of over 700 bankers allows Stifel to provide solutions that meet all of our clients’ evolving needs.
Notable Transactions
Advisor to Buyer
Mergers & Acquisitions
Food & Beverage
Jul 2026
Advisor to Buyer
Mergers & Acquisitions
Transportation & Logistics
Jul 2026
$ 100,000,000
Joint Bookrunning Manager
Registered Direct Offering
Biopharma
Jul 2026
Advisor to Buyer
Recapitalization
Healthcare Services
Jun 2026
$ 312,195,136
Joint Bookrunning Manager
IPO
Engineering & Construction, and Infrastructure
Jun 2026
Advisor to Seller
Affiliated
Healthcare Services
Jun 2026
$ 700,000,000
Joint Bookrunning Manager
Convertible Senior Notes
Biopharma
Jun 2026
$ 283,749,992
Joint Bookrunning Manager
Follow-on Offering
Biopharma
Jun 2026
$ 805,000,000
Joint Bookrunning Manager
Follow-on Offering
Biopharma
Jun 2026
$ 335,800,000
Lead Left Bookrunning Manager
Follow-on Offering
Engineering & Construction, and Infrastructure
Jun 2026
Exclusive Financial Advisor
Has Received a Minority Equity Investment
Automotive Aftermarket
Jun 2026
$ 240,000,000
Sole Placement Agent
Senior Secured Term Loan
Automotive Aftermarket
Jun 2026
$ 60,000,000
Sole Placement Agent
ABL Revolver
Automotive Aftermarket
Jun 2026
Advisor to Seller
Mergers & Acquisitions
Engineering & Construction, and Infrastructure
Jun 2026
$ 86,250,000,000
Co-Manager
IPO
Aerospace, Defense & Government Services
Jun 2026
$ 690,000,000
Joint Bookrunning Manager
Follow-on Offering
Biopharma
Jun 2026
$ 120,000,000
Joint Bookrunner
Registered Direct Offering
Biopharma
Jun 2026
$ 200,200,000
Joint Lead Bookrunning Manager
IPO
Energy & Natural Resources
Jun 2026
$ 650,000,000
Joint Bookrunning Manager
IPO
Aerospace, Defense & Government Services
Jun 2026
$ 575,000,000
Lead Left Bookrunning Manager
Follow-on Offering
Technology
May 2026
$ 240,000,000
Sole Placement Agent & Financial Advisor
Mergers & Acquisitions
Building Products
May 2026
$ 690,000,000
Joint Bookrunning Manager
Convertible Senior Notes
Biopharma
May 2026
Advisor to Buyer
Mergers & Acquisitions
Engineering & Construction, and Infrastructure
May 2026
$81,000,000
Advisor to Seller
Mergers & Acquisitions
Technology
Apr 2026
$ 500,000,000
Joint Bookrunning Manager
Senior Notes
Transportation & Logistics
Apr 2026
$ 1,915,000,000
Joint Lead Arranger
Senior Secured Credit Facilities
Transportation & Logistics
Apr 2026
$ 117,500,000
Left Bookrunning Manager
Registered Direct
Biopharma
Apr 2026
$ 700,350,000
Joint Bookrunning Manager
Follow-on Offering
Biopharma
Apr 2026
$ 191,250,000
Joint Bookrunning Manager
Initial Public Offering
Tools & Diagnostics
Apr 2026
Advisor to Buyer
Mergers & Acquisitions
Engineering & Construction, and Infrastructure
Apr 2026
Advisor to Buyer
Mergers & Acquisitions
Engineering & Construction, and Infrastructure
Apr 2026
$ 254,880,000
Joint Bookrunning Manager
Initial Public Offering
Biopharma
Apr 2026
$ 150,800,000
Joint Bookrunning Manager
Confidentially Marketed Follow-on Offering
Biopharma
Apr 2026
Advisor to Seller
Mergers & Acquisitions
Industrial & Environmental Services
Apr 2026
Sole Financial Advisor
Mergers & Acquisitions
Transportation & Logistics
Apr 2026
Advisor to Buyer
Mergers & Acquisitions
Electronics & Industrial Technology
Mar 2026
$ 1,200,000,000
Advisor to the Official Committee of Unsecured Creditors
Asset Sales in Chapter 11
Food & Beverage
Mar 2026
$ 130,000,000
Exclusive Advisor to Seller
Has Agreed to Divest Non-Core Assets
Industrial & Environmental Services
Mar 2026
$ 719,000,000
Joint Bookrunning Manager
Follow-on Offering
Biopharma
Mar 2026
$ 650,000,000
Joint Bookrunning Manager
Follow-on Offering
Biopharma
Mar 2026
$213,037,500
Joint Bookrunning Manager
Follow-on Offering
Energy & Natural Resources
Mar 2026
$ 230,000,000
Joint Bookrunning Manager
Follow-on Offering
Biopharma
Feb 2026
$ 200,000,000
Joint Bookrunning Manager
Initial Public Offering
Energy & Natural Resources
Feb 2026
Advisor to Seller
Mergers & Acquisitions
Engineering & Construction, and Infrastructure
Feb 2026
$ 150,000,000
Joint Bookrunning Manager
Follow-on Offering
Biopharma
Feb 2026
$ 172,500,000
Joint Bookrunning Manager
Initial Public Offering
Biopharma
Feb 2026
Advisor to Seller
Mergers & Acquisitions
Engineering & Construction, and Infrastructure
Feb 2026
$ 150,000,000
Joint Bookrunning Manager
Confidentially Marketed Follow-on Offering
Biopharma
Feb 2026
$1,150,000,000
Joint Bookrunning Manager
Follow-on and Concurrent Tangible Equity Unit Offering
Aerospace, Defense & Government Services
Feb 2026
$175,000,012
Lead Left Bookrunning Manager
Confidentially Marketed Follow-on Offering
Aerospace, Defense & Government Services
Feb 2026
$ 1,512,000,000
Joint Bookrunning Manager
Initial Public Offering
Industrial Technology, Engineering & Construction, and Infrastructure
Feb 2026
Advisor to Seller
Mergers & Acquisitions
Capital Goods
Jan 2026
Advisor to Seller
Mergers & Acquisitions
Engineering & Construction, and Infrastructure
Jan 2026
Advisor to Buyer
Mergers & Acquisitions
Diversified Industries
Jan 2026
Advisor to Seller
Mergers & Acquisitions
Tech-Enabled Services
Jan 2026
Sole Placement Agent
Senior Secured Credit Facilities
Industrial & Environmental Services
Jan 2026
Advisor to Seller
Has Received a Majority Growth Investment
Software
Dec 2025
$241,500,000
Lead Left Bookrunning Manager
Initial Public Offering
Engineering & Construction, and Infrastructure
Dec 2025
$402,500,000
Joint Bookrunning Manager
Follow-on Offering
Biopharma
Dec 2025
$692,300,000
Joint Bookrunning Manager
Follow-on Offering
Biopharma
Dec 2025
Lead Advisor to Seller
Mergers & Acquisitions
Transportation & Logistics
Dec 2025
Advisor to Seller
Mergers & Acquisitions
Infrastructure Services
Dec 2025
C$307,000,000
Advisor to Seller
Mergers & Acquisitions
Diversified Industries
Dec 2025
Exclusive Financial Advisor
Mergers & Acquisitions
Diversified Industries
Nov 2025
$600,000,000
Joint Bookrunning Manager
Convertible Senior Notes
Energy Transition
Nov 2025
Advisor to Seller
Mergers & Acquisitions
Transportation & Logistics
Nov 2025
Sole Placement Agent
Senior Secured Credit Facilities
Engineering & Construction, and Infrastructure
Nov 2025
Financial Advisor
Mergers & Acquisitions
Engineering & Construction, and Infrastructure
Nov 2025
$400,000,000
Joint Bookrunning Manager
Follow-On Offering
Aerospace, Defense & Government Services
Oct 2025
$135,000,000
Joint Bookrunning Manager
Confidentially Marketed Follow-on Offering
Biopharma
Oct 2025
$251,400,000
Joint Bookrunning Manager
Confidentially Marketed Follow-on Offering
Biopharma
Oct 2025
$135,000,000
Joint Bookrunning Manager
Confidentially Marketed Follow-on Offering
Biopharma
Oct 2025
$682,500,000
Joint Bookrunning Manager
IPO
Tech-Enabled Services
Oct 2025
$425,000,000
Joint Bookrunning Manager
Follow-On Offering
Aerospace, Defense & Government Services
Oct 2025
$316,250,000
Joint Bookrunning Manager
Confidentially Marketed Follow-on Offering
Biopharma
Oct 2025
Currency volume represents full credit to each underwriter. All transaction announcements appear as a matter of record only. Stifel collectively refers to Stifel, Nicolaus & Company, Incorporated and other affiliated broker-dealer subsidiaries of Stifel Financial Corp.
Leadership Team
C. Bradford Raymond
Global Co-Head of Institutional Equities and Advisory
New York
Thomas B. Michaud
KBW CEO & Global Co-Head of Institutional Equities and Advisory
New York
Thomas Weisel
Senior Managing Director and Director of Stifel Financial Corp.
San Francisco
Dick Himelfarb
Chairman, Investment Banking and Vice Chairman, Stifel Financial Corp.
Baltimore
Patrick Keeley
Vice Chairman, Investment Banking
Bethesda
Michael J. Kollender
Co-Head of Investment Banking
New York
Jason Stack
Co-Head of Mergers & Acquisitions
New York
Seth Rubin
Head of Global Equity Capital Markets
San Francisco
Chris Auld
Head of Leveraged Finance
New York
For more information, please contact us at [email protected]
